Tag: B-1 funding,EGFR,NSCLC,Non-Small Cell Lung Cancer,Press Releases,biomarker,blood-based cancer test,cancer diagnostics,liquid biopsy,lung cancer,molecular diagnostic,oncology
-
Biodesix Secures $10 Million in Series B-1 Funding
Funding to further the commercialization of VeriStrat®